SDZ - Sandoz Group AG - Stock Price & Dividends
Exchange: SIX Swiss Exchange • Country: Switzerland • Currency: CHF • Type: Common Stock • ISIN: CH1243598427
Generic Pharmaceuticals, Biosimilars, Active Pharmaceuticals Ingredients
Sandoz Group AG is a leading global player in the development, manufacturing, and marketing of high-quality generic pharmaceuticals and biosimilars, catering to diverse therapeutic areas worldwide.
The company's extensive portfolio covers a broad range of therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. This comprehensive approach enables Sandoz to provide affordable and accessible treatment options to patients across the globe.
In addition to its finished dosage forms, Sandoz also offers a robust portfolio of active pharmaceutical ingredients, which are essential components in the production of medicines. This dual approach allows the company to cater to the diverse needs of its customers and partners.
With a rich history dating back to 1886, Sandoz Group AG is headquartered in Basel, Switzerland, and has established itself as a trusted name in the global pharmaceutical industry. For more information, please visit their official website at https://www.sandoz.com.
Drawdown (Underwater) Chart
SDZ Stock Overview
| Market Cap in USD | 18,186m |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| TER | 0.00% |
| IPO / Inception |
SDZ Stock Ratings
| Growth 5y | 73.6 |
| Fundamental | -31.2 |
| Dividend | 22.5 |
| Rel. Performance vs Sector | 2.02 |
| Analysts | - |
| Fair Price Momentum | 34.90 CHF |
| Fair Price DCF | 7.66 CHF |
SDZ Dividends
| Dividend Yield 12m | 1.27% |
| Yield on Cost 5y | 1.55% |
| Dividends CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
SDZ Growth Ratios
| Growth 12m | 21.60% |
| Growth Correlation 12m | 88% |
| Growth Correlation 3m | 83% |
| CAGR 5y | 21.60% |
| CAGR/Mean DD 5y | 4.16 |
| Sharpe Ratio 12m | 0.48 |
| Alpha vs SP500 12m | 2.72 |
| Beta vs SP500 5y weekly | 0.66 |
| ValueRay RSI | 8.47 |
| Volatility GJR Garch 1y | 26.78% |
| Price / SMA 50 | -1.28% |
| Price / SMA 200 | 15.83% |
| Current Volume | 1100.1k |
| Average Volume 20d | 796.7k |
External Links for SDZ Stock
As of September 13, 2024, the stock is trading at CHF 35.35 with a total of 1,100,121 shares traded.
Over the past week, the price has changed by -0.51%, over one month by -1.04%, over three months by +12.15% and over the past year by +21.60%.
According to ValueRays Forecast Model, SDZ Sandoz Group AG will be worth about 38.2 in September 2025. The stock is currently trading at 35.35. This means that the stock has a potential upside of +7.92%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 37.1 | 4.92 |
| Analysts Target Price | - | - |
| ValueRay Target Price | 38.2 | 7.92 |